Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

EAN 2024

The 10th Congress of the European Academy of Neurology
29 Jun–02 July 2024 | Helsinki, Finland

EAN 2024

The 10th Congress of the European Academy of Neurology
29 Jun–02 July 2024 | Helsinki, Finland
Sweat dysfunction in ALS 2:09
Sweat dysfunction in ALS
Raffaele Dubbioso • 30 Jun 2024
The work of the PKU Association of Ireland 1:06
The work of the PKU Association of Ireland
Bernadette Sheehan Gilroy • 30 Jun 2024
Addressing depression in epilepsy 1:56
Addressing depression in epilepsy
Elinor Ben-Menachem • 30 Jun 2024
Pathophysiology and clinical manifestations of autoimmune encephalitis 1:53
Pathophysiology and clinical manifestations of autoimmune encephalitis
Antonio Malvaso • 30 Jun 2024
How to approach chronic drug-refractory epilepsy management 1:18
How to approach chronic drug-refractory epilepsy management
Elinor Ben-Menachem • 30 Jun 2024
Autonomic dysfunction in synucleinopathies 2:47
Autonomic dysfunction in synucleinopathies
Junie Shiwen Koay • 2 Jul 2024
Antibody screening tests for autoantibody-mediated neurological disorders 1:03
Antibody screening tests for autoantibody-mediated neurological disorders
Antonio Malvaso • 30 Jun 2024
Recognizing lifetime contributions to epilepsy research 2:03
Recognizing lifetime contributions to epilepsy research
Elinor Ben-Menachem • 30 Jun 2024
IGNITE trial: treating ALSP with TREM2 receptor agonists 3:13
IGNITE trial: treating ALSP with TREM2 receptor agonists
Zbigniew Wszolek • 30 Jun 2024
Indications for transcranial electrical brain stimulation 2:13
Indications for transcranial electrical brain stimulation
Andrea Antal • 30 Jun 2024
Real-world comparison of eculizumab and efgartigimod for generalized myasthenia gravis 3:05
Real-world comparison of eculizumab and efgartigimod for generalized myasthenia gravis
Francesco Sacca • 1 Jul 2024
Factors influencing RLS risk and progression 1:01
Factors influencing RLS risk and progression
Ambra Stefani • 2 Jul 2024
Impact of amantadine on cognitive function in Parkinson’s disease 1:24
Impact of amantadine on cognitive function in Parkinson’s disease
Anastasia Bougea • 30 Jun 2024
The Burden of Sleep/Wake Disorders: excessive daytime sleepiness and insomnia pilot study 4:10
The Burden of Sleep/Wake Disorders: excessive daytime sleepiness and insomnia pilot study
Marina Tüzün • 2 Jul 2024
Transient neonatal myasthenia gravis: detection and treatment 3:10
Transient neonatal myasthenia gravis: detection and treatment
Jenny Lindroos • 2 Jul 2024
Prolonged epileptic seizure treatment guidelines explained 2:14
Prolonged epileptic seizure treatment guidelines explained
Reetta Kälviäinen • 2 Jul 2024
The content of VJNeurology is intended for healthcare professionals